Have a personal or library account? Click to login
Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach Cover

Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach

Acta Pharmaceutica
Volume 70 (2020): Issue 1 (March 2020)
By: Chandni Saha,  N. Vishal Gupta and  R. S. Chandan  
Open Access
|Nov 2019
DOI: https://doi.org/10.2478/acph-2020-0008 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 17 - 33
Accepted on: Mar 20, 2019
Published on: Nov 1, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
atazanavir sulfate,
UPLC-MS,
“analytical quality by design”
Related subjects:
Pharmacy,
Pharmacy, other

© 2019 Chandni Saha, N. Vishal Gupta, R. S. Chandan, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 70 (2020): Issue 1 (March 2020)Next article